Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

There is currently no cure for dementia. However, there are treatments and support services that can help someone with the condition. These include drug and non-drug treatments, support, activities, ...

Getting an accurate and timely diagnosis of dementia is important. However, for younger people it can often take much longer. There can be specific reasons for this, including: Young-onset dementia is ...

The researchers theorise the protective effects of these drugs could be because they reduce inflammation, control infections ...

Alzheimer’s disease has afflicted Hannah Richardson’s family for generations. A rare genetic mutation, passed down from her ...

"External" causes like drug overdoses and homicide are killing young adults, but so are cardiometabolic diseases that previously mainly posed risks to older people. (Getty Creative) ...

In January 2025, the U.S. Food and Drug Administration (FDA ... AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the ...

The drug, Leqembi, can slow the progression of Alzheimer’s, the mind-robbing disease that afflicts millions. But it has been linked to brain swelling and bleeding, posing a challenge to ...